Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

The NHS should follow Denmark and offer chemotherapy at home, a leading MP has said. Sir Geoffrey Clifton-Brown, the Tory MP who chairs the public accounts committee, urged the health service to learn ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...

The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

A recent study shows that breast cancer survivors who undergo chemotherapy face prolonged physical decline, including fatigue ...

Tislelizumab plus chemotherapy is now FDA-approved for metastatic esophageal squamous cell carcinoma with a tumor PD-L1 ...

The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy ...